Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Intellia Therapeutics, Inc. (NTLA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 04/14/2022 |
4/A
| Keresty Georgia (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 1,569 shares
@ $0
Granted 2,534 options to buy
@ $83.59, valued at
$211.8k
|
|
| 03/04/2022 |
4/A
| BASTA JAMES (EVP, General Counsel) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 14,109 options to buy
@ $79.85, valued at
$1.1M
|
|
| 03/04/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 03/04/2022 |
4/A
| Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 20,203 options to buy
@ $79.85, valued at
$1.6M
|
|
| 03/04/2022 |
4/A
| Sepp-Lorenzino Laura (EVP, Chief Scientific Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 20,203 options to buy
@ $79.85, valued at
$1.6M
|
|
| 12/20/2018 |
4/A
| Goddard Glenn (See Remarks) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $19.27, valued at
$1.7M
|
|
|
|